MIR6827

Across TCGA pan-cancer cohorts, MIR6827 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6827’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MIR6827 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR6827 is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA, BRCA, and ESCA are the cancer types where MIR6827 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6827 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.489	.001	6	view →
BRCA	All	All	−0.296	<.001	6	view →
ESCA	All	II,III,IV	−0.860	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR6827–THCA

Open the THCA breakdown →